MORRISVILLE, N.C., July 16,
2024 /PRNewswire/ -- Metabolon, Inc., the global
leader in providing metabolomics solutions advancing a wide variety
of life science research, diagnostic, therapeutic development, and
precision medicine applications, today announced the expansion of
its metabolite library to include 70 pesticides, strengthening the
company's ability to provide comprehensive environmental exposure
insights via metabolomics analysis.
Nearly two billion people are involved in agriculture globally,
many of whom are exposed to pesticides on a regular basis. More
than one billion pounds of pesticides are applied annually in
the United States, while global
usage is around 5.6 billion pounds per year. However, there is a
limited understanding of how repeated pesticide exposure impacts
human health and reproductivity. Unlike other multiomics
solutions, metabolomics is uniquely suited to offer valuable
insights for researchers seeking to understand the exposome –
metabolomics not only reveals which pesticides we've been exposed
to but can also help assess the degree to which these pesticides
impact our health.
"Employing metabolomics to measure the exposome results in a
better understanding of the collective health effects of
environmental chemicals, including pesticides," said Ro Hastie,
President & CEO at Metabolon. "Our latest library expansion
underscores our commitment to advancing metabolomics research
and providing our customers with unique insights into the
exposome."
With this library expansion, Metabolon extends its coverage of
exposome-related molecules that can be identified with Level 1
certainty. These additions meaningfully bolster Metabolon's
library, further enabling a unique and holistic view of the
interaction between people and the chemicals to which they are
exposed, encompassing industrial, pharmaceutical, food, bacterial,
and fungal origins. For more information on Metabolon's
industry-leading library, please visit
https://www.metabolon.com/why-metabolon/identification/.
About Metabolon
Metabolon, Inc. is the global leader in metabolomics, with a
mission to deliver biochemical data and insights that expand and
accelerate the impact of life sciences research and complement
other 'omics' technologies. With more than 20 years, 10,000+
projects, 3,000+ publications, and ISO 9001:2015, CLIA, and CAP
certifications, Metabolon has developed industry-leading
scientific, technology, and bioinformatics techniques. Metabolon's
Global Discovery Panel is powered by the world's largest
proprietary metabolomics reference library. Metabolon's
industry-leading data and translational science expertise help
customers and partners address some of the most challenging and
pressing questions in the life sciences, accelerating research and
enhancing development success. The company offers scalable,
customizable multiomics solutions, including metabolomics
and lipidomics, that support customer needs from discovery
through clinical trials and product life-cycle management. For more
information, please visit www.metabolon.com and follow us
on LinkedIn and Twitter.
About Metabolomics
Metabolomics, the large-scale study
of all small molecules in a biological system, is the only 'omics
technology that provides a complete current-state functional
readout of a biological system. Metabolomics helps researchers see
beyond the genetic variation of individuals, capturing the combined
impact of genetic and external factors such as the effect of drugs,
diet, lifestyle, and the microbiome on human health. By
measuring thousands of discrete chemical signals that form
biological pathways in the body, metabolomics can reveal important
biomarkers, enabling a better understanding of a drug's mechanism
of action, pharmacodynamics, and safety profile, as well as
individual responses to therapy.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/metabolon-expands-library-to-include-70-pesticides-advancing-human-exposome-insights-through-metabolomics-302197251.html
SOURCE Metabolon, Inc.